124 related articles for article (PubMed ID: 34002415)
1. Identification of kinases and kinase inhibitors for the differential targeting of Wnt/β-catenin signaling in gastric cancer subtypes.
Bhaskar Rao D; Devanandan HJ; Ganesan K
Drug Dev Res; 2021 Dec; 82(8):1182-1192. PubMed ID: 34002415
[TBL] [Abstract][Full Text] [Related]
2. The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models.
Tam BY; Chiu K; Chung H; Bossard C; Nguyen JD; Creger E; Eastman BW; Mak CC; Ibanez M; Ghias A; Cahiwat J; Do L; Cho S; Nguyen J; Deshmukh V; Stewart J; Chen CW; Barroga C; Dellamary L; Kc SK; Phalen TJ; Hood J; Cha S; Yazici Y
Cancer Lett; 2020 Mar; 473():186-197. PubMed ID: 31560935
[TBL] [Abstract][Full Text] [Related]
3. Delineation of gastric tumors with activated ERK/MAPK signaling cascades for the development of targeted therapeutics.
Pandian J; Ganesan K
Exp Cell Res; 2022 Jan; 410(1):112956. PubMed ID: 34864005
[TBL] [Abstract][Full Text] [Related]
4. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
5. Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer.
Arqués O; Chicote I; Puig I; Tenbaum SP; Argilés G; Dienstmann R; Fernández N; Caratù G; Matito J; Silberschmidt D; Rodon J; Landolfi S; Prat A; Espín E; Charco R; Nuciforo P; Vivancos A; Shao W; Tabernero J; Palmer HG
Clin Cancer Res; 2016 Feb; 22(3):644-56. PubMed ID: 26224873
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of miR-501-5p activates the wnt/β-catenin signaling pathway and enhances stem cell-like phenotype in gastric cancer.
Fan D; Ren B; Yang X; Liu J; Zhang Z
J Exp Clin Cancer Res; 2016 Nov; 35(1):177. PubMed ID: 27846906
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional coexpression network reveals the involvement of varying stem cell features with different dysregulations in different gastric cancer subtypes.
Kalamohan K; Periasamy J; Bhaskar Rao D; Barnabas GD; Ponnaiyan S; Ganesan K
Mol Oncol; 2014 Oct; 8(7):1306-25. PubMed ID: 24917244
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of Wnt/β-catenin signaling by protein kinases in hepatocellular carcinoma and its therapeutic application.
Li Q; Sun M; Wang M; Feng M; Yang F; Li L; Zhao J; Chang C; Dong H; Xie T; Chen J
Cancer Sci; 2021 May; 112(5):1695-1706. PubMed ID: 33605517
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive pharmacogenomic characterization of gastric cancer.
Sa JK; Hong JY; Lee IK; Kim JS; Sim MH; Kim HJ; An JY; Sohn TS; Lee JH; Bae JM; Kim S; Kim KM; Kim ST; Park SH; Park JO; Lim HY; Kang WK; Her NG; Lee Y; Cho HJ; Shin YJ; Kim M; Koo H; Kim M; Seo YJ; Kim JY; Choi MG; Nam DH; Lee J
Genome Med; 2020 Feb; 12(1):17. PubMed ID: 32070411
[TBL] [Abstract][Full Text] [Related]
10. Label-Free Quantitative Proteomics Combined with Biological Validation Reveals Activation of Wnt/β-Catenin Pathway Contributing to Trastuzumab Resistance in Gastric Cancer.
Liu W; Yuan J; Liu Z; Zhang J; Chang J
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986466
[TBL] [Abstract][Full Text] [Related]
11. Identification of MAP kinase pathways as therapeutic targets in gallbladder carcinoma using targeted parallel sequencing.
Li M; Chen L; Qu Y; Sui F; Yang Q; Ji M; Shi B; Chen M; Hou P
Oncotarget; 2017 May; 8(22):36319-36330. PubMed ID: 28422736
[TBL] [Abstract][Full Text] [Related]
12. Effect of pantoprazole on human gastric adenocarcinoma SGC7901 cells through regulation of phospho‑LRP6 expression in Wnt/β-catenin signaling.
Shen W; Zou X; Chen M; Shen Y; Huang S; Guo H; Zhang L; Liu P
Oncol Rep; 2013 Aug; 30(2):851-5. PubMed ID: 23754096
[TBL] [Abstract][Full Text] [Related]
13. Regorafenib inhibited gastric cancer cells growth and invasion via CXCR4 activated Wnt pathway.
Lin XL; Xu Q; Tang L; Sun L; Han T; Wang LW; Xiao XY
PLoS One; 2017; 12(5):e0177335. PubMed ID: 28489887
[TBL] [Abstract][Full Text] [Related]
14. 2,4-Diamino-Quinazoline, a Wnt Signaling Inhibitor, Suppresses Gastric Cancer Progression and Metastasis.
Chang TS; Lu CK; Hsieh YY; Wei KL; Chen WM; Tung SY; Wu CS; Chan MWY; Chiang MK
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824603
[TBL] [Abstract][Full Text] [Related]
15. Identification of the targeted therapeutic potential of doxycycline for a subset of gastric cancer patients.
Pandian J; Panneerpandian P; Devanandan HJ; Sekar BT; Balakrishnan K; Selvarasu K; Muthupandi K; Ganesan K
Ann N Y Acad Sci; 2020 May; 1467(1):94-111. PubMed ID: 31944316
[TBL] [Abstract][Full Text] [Related]
16. Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib.
Lachenmayer A; Alsinet C; Savic R; Cabellos L; Toffanin S; Hoshida Y; Villanueva A; Minguez B; Newell P; Tsai HW; Barretina J; Thung S; Ward SC; Bruix J; Mazzaferro V; Schwartz M; Friedman SL; Llovet JM
Clin Cancer Res; 2012 Sep; 18(18):4997-5007. PubMed ID: 22811581
[TBL] [Abstract][Full Text] [Related]
17. Acetyl-11-keto-β-boswellic acid (AKBA) inhibits human gastric carcinoma growth through modulation of the Wnt/β-catenin signaling pathway.
Zhang YS; Xie JZ; Zhong JL; Li YY; Wang RQ; Qin YZ; Lou HX; Gao ZH; Qu XJ
Biochim Biophys Acta; 2013 Jun; 1830(6):3604-15. PubMed ID: 23500016
[TBL] [Abstract][Full Text] [Related]
18. Curcumin Inhibits Gastric Carcinoma Cell Growth and Induces Apoptosis by Suppressing the Wnt/β-Catenin Signaling Pathway.
Zheng R; Deng Q; Liu Y; Zhao P
Med Sci Monit; 2017 Jan; 23():163-171. PubMed ID: 28077837
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Glycogen Synthase Kinase Inhibitors That Regulate Cytochrome P450 Expression in Primary Human Hepatocytes by Activation of β-Catenin, Aryl Hydrocarbon Receptor and Pregnane X Receptor Signaling.
Briolotti P; Chaloin L; Balaguer P; Da Silva F; Tománková V; Pascussi JM; Duret C; Fabre JM; Ramos J; Klieber S; Maurel P; Daujat-Chavanieu M; Gerbal-Chaloin S
Toxicol Sci; 2015 Nov; 148(1):261-75. PubMed ID: 26259606
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity and activation of the Wnt/beta-catenin pathway in mouse embryonic stem cells treated with four GSK3 inhibitors.
Naujok O; Lentes J; Diekmann U; Davenport C; Lenzen S
BMC Res Notes; 2014 Apr; 7():273. PubMed ID: 24779365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
